Novartis AG

Novartis AG

• Actavis buying Warner Chilcott in $8.5B deal

  Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion which would create the third-biggest specialty ... 

• Hospital to probe East German medical trials

  Berlin's renowned Charite hospital said Monday it plans to investigate allegations that patients in communist East Germany were used as unwitting ... 

• 

  Novartis posts profit gain thanks to new drugs

  Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and ... 

• 

  Drug maker Novartis loses India patent battle

  India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that ... 

• India rejects Bayer plea against cheap cancer drug

  India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling ... 

• 

  Swiss voters approve tough limits on bosses' pay

  Swiss voters voiced their anger at perceived corporate greed Sunday by approving a plan to boost shareholders' say on executive pay. Some 67.9 percent ... 

• 

  Novartis chairman foregoes $78 million payout

  Swiss drugmaker Novartis AG has agreed with its outgoing chairman to scrap plans for a farewell non-compete deal that could have netted him up to 72 ... 

• 

  Novartis Q4 net profit rebounds to $2.1 billion

  Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time ...